Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.

S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, C. Wauters, L. Strobbe, C. Mandigers, P. Bult, W. Oyen, W. van der Graaf and H. van Laarhoven

Non-invasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies

S. Heskamp, W. Hobo, J. Molkenboer-Kuenen, D. Olive, W. Oyen, H. Dolstra and O. Boerman

Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell Cancer.

M. Boers-Sonderen, I. Desar, J. Fütterer, S. Mulder, L. De Geus-Oei, P. Mulders, W. VanDer Graaf, W. Oyen and C. Van Herpen

Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.

M. Janssen, O. Meulenbroek, S. Steens, B. Góraj, M. Bosch, P. Koopmans and R. Kessels

Direct dynamic measurement of intracellular and extracellular lactate in small-volume cell suspensions with (13)C hyperpolarised NMR.

V. Breukels, K. Jansen, F. van Heijster, A. Capozzi, P. van Bentum, J. Schalken, A. Comment and T. Scheenen

111In-exendin uptake in the pancreas correlates with the beta cell mass and not with the alpha cell mass

M. Brom, L. Joosten, C. Frielink, O. Boerman and M. Gotthardt

Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in 18F-FDG PET/CT

E. Ter Voert, H. van Laarhoven, P. Kok, W. Oyen, E. Visser and L. de Geus-Oei

Imaging Integrin αvβ3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts

S. Terry, K. Abiraj, C. Frielink, L. van Dijk, J. Bussink, W. Oyen and O. Boerman

Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts?

S. Terry, K. Abiraj, J. Lok, D. Gerrits, G. Franssen, W. Oyen and O. Boerman

Radiolabeled imaging probes targeting angiogenesis for personalized medicine

S. Terry, M. Rijpkema, K. Abiraj, W. van der Graaf, W. Oyen and O. Boerman

18F-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis

I. Kouijzer, C. Bleeker-Rovers and W. Oyen

Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer

K. Chatalic, G. Franssen, W. van Weerden, W. McBride, P. Laverman, E. de Blois, B. Hajjaj, L. Brunel, D. Goldenberg, J. Fehrentz, J. Martinez, O. Boerman and M. de Jong

Recessive TTN truncating mutations define novel forms of core myopathy with heart disease

C. Chauveau, C. Bonnemann, C. Julien, A. Kho, H. Marks, B. Talim, P. Maury, M. Arne-Bes, E. Uro-Coste, A. Alexandrovich, A. Vihola, S. Schafer, B. Kaufmann, L. Medne, N. Hübner, A. Foley, M. Santi, B. Udd, H. Topaloglu, S. Moore, M. Gotthardt, M. Samuels, M. Gautel and A. Ferreiro

In-treatment assessment of response in locally advanced NSCLC: Paving the way for personalized medicine

E. Usmanij, J. Bussink and L. de Geus-Oei

Antibody-based imaging of Prostate Cancer

S. Lütje

Anti-CEA Antibody Fragments Labeled with [(18)F]AlF for PET Imaging of CEA-Expressing Tumors

S. Lütje, G. Franssen, R. Sharkey, P. Laverman, E. Rossi, D. Goldenberg, W. Oyen, O. Boerman and W. McBride

Monitoring the biological effect of BMP-2 release on bone healing by PET/CT

M. Ventura, O. Boerman, G. Franssen, E. Bronkhorst, J. Jansen and X. Walboomers

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody

S. Lütje, M. Rijpkema, G. Franssen, G. Fracasso, W. Helfrich, A. Eek, W. Oyen, M. Colombatti and O. Boerman

SPECT vs. PET monitoring of bone defect healing and biomaterial performance in vivo

M. Ventura, G. Franssen, E. Oosterwijk, O. Boerman, J. Jansen and X. Walboomers

Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer

S. Lütje, M. Rijpkema, D. Goldenberg, C. van Rij, R. Sharkey, W. McBride, G. Franssen, C. Frielink, W. Helfrich, W. Oyen and O. Boerman